Calixa Therapeutics Gets Investment From Domain

Calixa Therapeutics, a stealth San Diego biopharmaceuticals firm, has quietly raised a round of venture capital from Domain Associates, socalTECH has learned. According to Domain, Calixa is focused on developing, acquiring and commercializing hospital-based anti-infective therapies. No details of the funding have been announced. Eckhard Weber, a Partner at Domain Associates, is currently listed as interim CEO of the firm. More information »